Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationJoanna M. Wardlaw, Martin Dichgans, Eric E. Smith et al.|The Lancet Neurology|2013Cited by 5.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseRandall J. Bateman, John C. Morris, Chengjie Xiong et al.|New England Journal of Medicine|2012Cited by 3.8k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's DiseaseStephen Salloway, H. Robert Brashear, Reisa A. Sperling et al.|New England Journal of Medicine|2014Cited by 2k
Brain Imaging in Alzheimer DiseaseKeith A. Johnson, William E. Klunk, Nick C. Fox et al.|Cold Spring Harbor Perspectives in Medicine|2012Cited by 863
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseStephen Salloway, Michael Grundman, Reisa A. Sperling et al.|Neurology|2009Cited by 739